The Cancer Institute of New Jersey

Robert S DiPaola, MD

	Director, CINJ, RWJMS The Cancer Institute of New Jersey (CINJ) 195 Little Albany Street New Brunswick, NJ 08903 dipaolrs@umdnj.edu

Clinical Specialty: Medical Oncology, Prostate cancer, Bladder Cancer, Renal Cancer, Testicular Cancer

DiPaola RS, Morton RA Proven and Unproven Therapy for benign prostatic hyperplasia New Engl J Med . 2006; 354(6):632-4.
Gray R, Manola J, Saxman S, Wright J, Dutcher J, Atkins M, Carducci M, See W, Sweeney C, Liu G, Stein M, Dreicer R, Wilding G, DiPaola RS Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group Clin Cancer Res. 2006; 12(7):1966-9.
Beekman KW, Colevas AD, Cooney K, DiPaola R, Dunn RL, Gross M, Keller ET, Pienta KJ, Ryan CJ, Smith D, Hussain M Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design Clin Genitourin Cancer . 2006; 4(4):299-302.
Lu-Yao G, Moore DF, Oleynick J, DiPaola RS, Yao SL Use of hormonal therapy among men with metastatic prostate cancer J Urol . 2006; 176:526-531.
Banach-Petrosky W, Ouyang X, Ga H, Nader K, Ji Y, Suh N, DiPaola RS, Abate-Shen C Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1; Pten mutant mice Clin Cancer Res . 2006; 12(19):5895-901.
Lu-Yao G, Moore DF, Oleynick J, DiPaola RS, Yao SL Population-based study of hormonal therapy and survival in men with metastatic prostate cancer J Urol . 2007; 177(2):535-9.
Jin S, DiPaola RS, White E Metabolic Catastrophe: A Means to Cancer Cell Death J. Cell Science. 2007; 120(Pt 3):379-83.
Goodin, Lambert G., Gallo M., DiPaola RS Clinical and Biochemical Effect of Soy in Men Cancer Epidemiol Biomarkers Prev . 2007; 16(4):829-33.
Bradley DA, Hussain M, DiPaola R. S., Kantoff P Bone Directed Therapies for Prostate Cancer J Urol . 2007; 178 (3 Pt 2):S42-8.
DiPaola RS, Lattime EC Bacillus Calmette-Guerin Mechanism of Action: The Role of Immunity, Apoptosis, Necrosis and Autophagy J Urol . 2007; 178 (5): 1840-1.
Kibel AS, Rosenbaum E, Kattan MW, Picus J, Dreicer R, Klein EA, Chatta GS, Nelson JB, DiPaola RS, Roth BJ, Cookson MS, Wilding G, Jarrard DF, Beer TM, Ryan CW, Petrylak DP, Benson MC, Partin AW, Garrett-Mayer E, Eisenberger MA. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study J Urol . 2007; 177(5):1777-81.
Small EJ, Fontana J, Tannir N, DiPaola RS, Wilding G, Rubin M, Iacona RB, Kabbinavar FF A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer BJU Int . 2007; 100(4):765-9.
Kantoff PW, Beer TM, D'Amico AV, DiPaola RS, Eisenberger MA, Hussain MH, Kelly WK, Mathew P, Morris MJ, Ryan CJ, Sandler HM, Thompson IM, Carroll PR Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference J Urol . 2007; 178(3 Pt 2):S5-S8.
DiPaola RS, Gallo M Hearsay medicine is not evidence-based medicine Clin Cancer Res . 2008; 14(2):337-8.
Lu-Yao G, Albertson PC, Moore D, Shih W, Y Lin, DiPaola RS, Yao S Survival Following Primary Androgen Deprivation Therapy Among Men with Localized Prostate Cancer JAMA. 2008; 300(2):173-181.

Research

The Cancer Institute of New Jersey CINJ\|Contact CINJ	Robert Wood Johnson Medical School RWJMS\|Contact RWJMS\|Service Level Agreement	University of Medicine and Dentistry of New Jersey UMDNJ\|Contact UMDNJ
© 2008 Robert Wood Johnson Medical School, all rights reserved.